Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride provides potassium ions necessary for nerve conduction, muscle contraction, and maintenance of intracellular tonicity. Dextrose 5% provides a source of calories and is metabolized to carbon dioxide and water, supplying energy. Sodium chloride provides sodium and chloride ions for electrolyte balance and maintenance of osmotic pressure.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion at a rate not exceeding 10-20 mEq/hour of potassium; typical dose for hypokalemia: 20-40 mEq potassium chloride per liter of IV fluid, infused at a rate to correct deficit. Actual dose depends on serum potassium level and clinical status.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable for combined electrolyte/caloric solution; potassium distribution half-life ~1-1.5 hours; for potassium, elimination half-life depends on renal function (normal: ~6-8 hours, anuria: prolonged).
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% of potassium ion excreted by kidneys (distal tubular secretion and reabsorption); <10% fecal (via gastrointestinal secretion). Dextrose and sodium chloride components are fully metabolized or excreted renally.
Category C
Category A/B
Electrolyte
Electrolyte